MEDOCHEMIE was established in 1976 in Cyprus by Dr Andreas Pittas and is still driven by the same philosophy: "to provide every human being around the globe with quality and affordable drug treatment in a manner that supports sustainability". We develop, license, manufacture, market, and distribute branded generic and super-generic pharmaceutical products as well as our own patented brands. The driving force behind Medochemie is our 1,370 multinational, talented, quality-focused employees, many of whom hold advanced degrees. We offer opportunities for suitably qualified applicants in a wide range of roles at our manufacturing plants, scientific laboratories or sales offices worldwide.